171 related articles for article (PubMed ID: 21655429)
1. Indispensable roles of mammalian Cbl family proteins as negative regulators of protein tyrosine kinase signaling: Insights from in vivo models.
Naramura M; Band V; Band H
Commun Integr Biol; 2011 Mar; 4(2):159-62. PubMed ID: 21655429
[TBL] [Abstract][Full Text] [Related]
2. Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases.
Mohapatra B; Ahmad G; Nadeau S; Zutshi N; An W; Scheffe S; Dong L; Feng D; Goetz B; Arya P; Bailey TA; Palermo N; Borgstahl GE; Natarajan A; Raja SM; Naramura M; Band V; Band H
Biochim Biophys Acta; 2013 Jan; 1833(1):122-39. PubMed ID: 23085373
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic Signaling by Leukemia-Associated Mutant Cbl Proteins.
Nadeau S; An W; Palermo N; Feng D; Ahmad G; Dong L; Borgstahl GE; Natarajan A; Naramura M; Band V; Band H
Biochem Anal Biochem; 2012 Jul; Suppl 6(1):. PubMed ID: 23997989
[TBL] [Abstract][Full Text] [Related]
4. The Cbl family proteins: ring leaders in regulation of cell signaling.
Swaminathan G; Tsygankov AY
J Cell Physiol; 2006 Oct; 209(1):21-43. PubMed ID: 16741904
[TBL] [Abstract][Full Text] [Related]
5. Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders.
Naramura M; Nadeau S; Mohapatra B; Ahmad G; Mukhopadhyay C; Sattler M; Raja SM; Natarajan A; Band V; Band H
Oncotarget; 2011 Mar; 2(3):245-50. PubMed ID: 21422499
[TBL] [Abstract][Full Text] [Related]
6. Negative regulation of PTK signalling by Cbl proteins.
Thien CB; Langdon WY
Growth Factors; 2005 Jun; 23(2):161-7. PubMed ID: 16019438
[TBL] [Abstract][Full Text] [Related]
7. Structural Determinants of the Gain-of-Function Phenotype of Human Leukemia-associated Mutant CBL Oncogene.
Nadeau SA; An W; Mohapatra BC; Mushtaq I; Bielecki TA; Luan H; Zutshi N; Ahmad G; Storck MD; Sanada M; Ogawa S; Band V; Band H
J Biol Chem; 2017 Mar; 292(9):3666-3682. PubMed ID: 28082680
[TBL] [Abstract][Full Text] [Related]
8. Negative regulation of FcepsilonRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b.
Qu X; Sada K; Kyo S; Maeno K; Miah SM; Yamamura H
Blood; 2004 Mar; 103(5):1779-86. PubMed ID: 14604964
[TBL] [Abstract][Full Text] [Related]
9. The Cbl family of signal transduction molecules.
Smit L; Borst J
Crit Rev Oncog; 1997; 8(4):359-79. PubMed ID: 9622055
[TBL] [Abstract][Full Text] [Related]
10. The Cbl family of ubiquitin ligases: critical negative regulators of tyrosine kinase signaling in the immune system.
Rao N; Dodge I; Band H
J Leukoc Biol; 2002 May; 71(5):753-63. PubMed ID: 11994499
[TBL] [Abstract][Full Text] [Related]
11. Cbl and human myeloid neoplasms: the Cbl oncogene comes of age.
Kales SC; Ryan PE; Nau MM; Lipkowitz S
Cancer Res; 2010 Jun; 70(12):4789-94. PubMed ID: 20501843
[TBL] [Abstract][Full Text] [Related]
12. SLAP2 Adaptor Binding Disrupts c-CBL Autoinhibition to Activate Ubiquitin Ligase Function.
Wybenga-Groot LE; Tench AJ; Simpson CD; Germain JS; Raught B; Moran MF; McGlade CJ
J Mol Biol; 2021 Apr; 433(8):166880. PubMed ID: 33617900
[TBL] [Abstract][Full Text] [Related]
13. The RING finger domain of Cbl is essential for negative regulation of the Syk tyrosine kinase.
Ota S; Hazeki K; Rao N; Lupher ML; Andoniou CE; Druker B; Band H
J Biol Chem; 2000 Jan; 275(1):414-22. PubMed ID: 10617633
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of a novel, transforming allele of the c-Cbl proto-oncogene from a murine macrophage cell line.
Bisson SA; Ujack EE; Robbins SM
Oncogene; 2002 May; 21(23):3677-87. PubMed ID: 12032836
[TBL] [Abstract][Full Text] [Related]
15. c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses.
Thien CB; Langdon WY
Biochem J; 2005 Oct; 391(Pt 2):153-66. PubMed ID: 16212556
[TBL] [Abstract][Full Text] [Related]
16. Structural flexibility regulates phosphopeptide-binding activity of the tyrosine kinase binding domain of Cbl-c.
Takeshita K; Tezuka T; Isozaki Y; Yamashita E; Suzuki M; Kim M; Yamanashi Y; Yamamoto T; Nakagawa A
J Biochem; 2012 Nov; 152(5):487-95. PubMed ID: 22888118
[TBL] [Abstract][Full Text] [Related]
17. Coordinated regulation of the tyrosine phosphorylation of Cbl by Fyn and Syk tyrosine kinases.
Deckert M; Elly C; Altman A; Liu YC
J Biol Chem; 1998 Apr; 273(15):8867-74. PubMed ID: 9535867
[TBL] [Abstract][Full Text] [Related]
18. The Cbl protooncogene product: from an enigmatic oncogene to center stage of signal transduction.
Miyake S; Lupher ML; Andoniou CE; Lill NL; Ota S; Douillard P; Rao N; Band H
Crit Rev Oncog; 1997; 8(2-3):189-218. PubMed ID: 9570294
[TBL] [Abstract][Full Text] [Related]
19. Negative regulation of receptor tyrosine kinases: unexpected links to c-Cbl and receptor ubiquitylation.
Rubin C; Gur G; Yarden Y
Cell Res; 2005 Jan; 15(1):66-71. PubMed ID: 15686631
[TBL] [Abstract][Full Text] [Related]
20. Physical and functional association of the cbl protooncogen product with an src-family protein tyrosine kinase, p53/56lyn, in the B cell antigen receptor-mediated signaling.
Tezuka T; Umemori H; Fusaki N; Yagi T; Takata M; Kurosaki T; Yamamoto T
J Exp Med; 1996 Feb; 183(2):675-80. PubMed ID: 8627181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
